All Clinical Trials

Therapeutic

A Historical-controlled, Multicenter, Double-blind, Randomized Trial to Assess the Efficacy and Safety of Conversion to Lacosamide 400mg/day monotherapy in subjects with Partial-onset Seizures SP902

A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson’s Disease.

A Multi-arm Phase I Study of BMS-936558 in Combination with Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, or Carboplatin/Paclitaxel in Subjects with Chemotherapy-Naive Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC)

A Multicenter, Open-label Extension Trial to Assess the long-term use of Lacosamide Monotherapy and safety of Lacosamide Monotherapy and Adjuntive Therapy in Subjects with Partial-onset Seizures. Trial Number SP904

A Non-Randomized, Open-label, Multi-Center, Multi-Cohort Phase 2 Study Evaluating the Efficacy and Safety of STA-9090 in Subjects with Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)

A Phase 1-2 trial of MM-121 in Combination with Erlotinib in Three Groups of Patients with Non-Small Cell Lung Cancer

A Phase 2 Randomized Open-label Study of Erlotinib plus Tivantinib (ARQ 197) versus Single Agent Chemotherapy in Previously Treated KRAS Mutation Positive Subjects with Locally Advanced or Metastatic Non–Small Cell Lung Cancer

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GS-6624 Combined with FOLFIRI as Second Line Treatment for Metastatic KRAS Mutant Colorectal Adenocarcinoma that Has Progressed Following a First Line Oxaliplatin- and Fluoropyrimidine-Containing Regimen.

A Phase 2a Study to Evaluate the Safety and Tolerability of OCR-002 (ornithine phenylacetate) in the Treatment of Patients with Acute Liver Failure due to Acetaminophen Overdose (STOP-ALF)

A Phase 3, Randomized, Controlled, Double-Blind, Multinational Clinical Study of the Efficacy and Safety of Vosaroxin and Cytarabine versus Placebo and Cytarabine in Patients with First Relapsed or Refractory Acute Myeloid Leukemia (VALOR)

A Phase 3, Randomized, Open Label Trial of Lenalidomide/dexamethasone With or Without Elotuzumab in Relapsed or Refractory Multiple Myeloma

A Phase 3, Safety and Efficacy Study of Boceprevir/Peginterferon Alfa-2a/ribavirin in Chronic HCV Genotype 1 IL28B CC Subjects

A Phase I Study of Cyberknife® Partial Breast Irradiation (PBI) for Early Stage Breast Cancer

A Phase I dose escalation study of ARQ 761 (Beta-Lapachone) in adult patients with advanced solid tumors

A Phase I open-label study of the safety and pharmacokinetics of escalating doses of DNIB0600A in patients with non-small cell lung cancer and platinum-resistant ovarian cancer

A Phase I/II Study of Bavituximab and Sorafenib In Patients With Advanced Hepatocellular Carcinoma

A Phase I/II Study of Erlotinib and Romidepsin in Advanced Non-Small Cell Lung Cancer

A Phase II Multi-Center Study of Concomitant Cetuximab and Cisplatin with Re-Irradiation using Intensity-Modulated Radiotherapy in Patients with Recurrent Squamous Cell Carcinoma of the Head-and-Neck

A Phase II Randomized Trial of Paclitaxel, Carboplatin, Bevacizumab with or without IMC-A12 in Patients with Advanced Non-Squamous, Non-Small Cell Lung Cancer

A Phase II Study of Gemcitabine, Carboplatin and Poly (ADP-Ribose) Polymerase (PARP) Inhibitor BSI-201 (Iniparib) in the Neoadjuvant Treatment of Triple-Negative or BRCA Mutation-Associated Breast Cancer

A Phase II Trial of Erlotinib (Tarceva®) in Combination with Stereotactic Body Radiation Therapy (SBRT) for Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

A Phase II Trial of Response Adapted Therapy of Stage III-lV Hodgkin Lymphoma Using Early Interim FDG-PET Imaging.

A Phase II study of CP-868,596 (crenolanib), a selective and potent inhibitor of PDGFR, for the treatment of adult gliomas

A Phase II, single-arm study of orally administered BKM120 as second-line therapy in patients with advanced endometrial carcinoma

A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy versus High-Dose Interferon Alfa-2b for Resected High-risk Melanoma

A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (> 4 cm) -IIIA Non-Small Cell Lung Cancer (NSCLC)

A Phase III Study of Chemotherapy and Chemoradiotherapy With or Without HyperAcute®-Pancreas Immunotherapy in Subjects with Surgically Resected Pancreatic Cancer

A Phase III Surgical Trial to Evaluate the Benefit of a Standard versus an Extended Pelvic Lymphadenectomy Performed at Time of Radical Cystectomy for Muscle Invasive Urothelial Cancer

A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of V212 in Recipients of Autologous Hematopoietic Cell Transplants (HCTs)

A Phase III, Multi-Center, Randomized, Controlled Study to Assess the Efficacy and Safety of ON 01910.Na Administered as a 72-Hour Continuous Intravenous Infusion Every Other Week in Myelodysplastic Syndrome Patients with Excess Blasts Relapsing After, or Refractory to, or Intolerant to Azacitidine or Decitabine

A Phase III, Randomized Trial of Surgical Resection With or Without BCG Versus Best Medical Therapy as Initial Treatment in Stage IV Melanoma

A Pilot and Phase II Study of Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients with Stage II or III Rectal Adenocarcinoma

A Randomized Controlled Study of YONDELIS (Trabectedin) or Dacarbazine for the Treatment of Advanced Liposarcoma or Leiomyosarcoma Previously Treated with an Anthracycline and Ifosfamide

A Randomized Phase 2 Study of a Human anti-PDGFRa monoclonal antibody (IMC-3G3) with Paclitaxel/Carboplatin or Paclitaxel/Carboplatin Alone in previously untreated patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer

A Randomized Phase III Trial of the value of early local therapy for the intact primary tumor in patients with metastatic breast cancer

A Randomized Placebo-Controlled Study of Lovastatin in Children with Neurofibromatosis Type 1

A Randomized, Multicenter, Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects with Relapsed Multiple Myeloma

A Single-Masked, Randomized, Multi-Center, 2-Arm Parallel Study Comparing the Safety and Effectiveness of Bulkamid and Contigen as Bulking Agents for the Treatment of Stress Urinary Incontinence in Females

A Trial of Single Autologous Transplant with or without Consolidation Therapy versus Tandem Autologous Transplant with Lenalidomide Maintenance for Patients with Multiple Myeloma

A phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and safety of lenalidomide (Revlimid®) as maintenance therapy for patients with B-cell chronic lymphocytic leukemia following second-line therapy

A phase I/II study of nab-paclitaxel, cisplatin and cetuximab with concurrent radiation therapy for local-regionally advanced head-and-neck squamous cell carcinoma

A phase II randomized trial of fulvestrant and anastrozole as consolidation therapy in postmenopausal women with advanced non-small cell lung cancer who have received first-line platinum-based chemotherapy with or without bevacizumab

A phase II, multi-center, non-randomized, open-label study of TKI258 in patients with relapsed or refractory multiple myeloma, who are with or without t(4;14) translocation

A randomized Phase III, double-blind, placebo-controlled multicenter trial of daily everolimus in combination with trastuzumab and vinorelbine, in pretreated women with HER2/neu over-expressing locally advanced or metastatic breast cancer

A randomized, double-blind, placebo-controlled, multiple dose study to evaluate the safety, tolerability, pharmacokinetic, pharmacodynamics and clinical effect of AMG557 in subject with subacute cutaneous lupus erythematosus (SCLE)

AALL07P1, A Phase II Pilot Trial of Bortezomib (PS-341, Velcade, IND# 58,443) in Combination with Intensive Re-Induction Therapy for Children with Relapsed Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LL) A Groupwide Pilot Study

AAML1031, A Phase III Randomized Trial for Patients with de novo AML using Bortezomib and Sorafenib (IND#114480; NSC# 681239, NSC# 724772) for Patients with High Allelic Ratio FLT3/ITD

ACCL0933, A Randomized Open-Label Trial of Caspofungin versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)

ACNS0331: A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy (18 Gy) and Chemotherapy in Children with Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized Trial

ACNS0821, Temozolomide with Irinotecan Versus Temozolomide, Irinotecan plus Bevacizumab for Recurrent/Refractory Medulloblastoma/CNS PNET of Childhood, A COG Randomized Phase II Screening Trial

AN INTERGROUP PHASE II CLINICAL TRIAL FOR ADOLESCENTS AND YOUNG ADULTS WITH UNTREATED ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

AN OPEN-LABEL, RANDOMIZED, PHASE 3 STUDY OF INOTUZUMAB OZOGAMICIN ADMINISTERED IN COMBINATION WITH RITUXIMAB COMPARED TO DEFINED INVESTIGATORS CHOICE THERAPY IN SUBJECTS WITH RELAPSED OR REFRACTORY CD22-POSITIVE AGGRESSIVE NON-HODGKIN LYMPHOMA WHO ARE NOT CANDIDATES FOR INTENSIVE HIGH-DOSE CHEMOTHERAPY

AREN0321, Treatment of High Risk Renal Tumors

AREN0533: Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors

An Open Label, Multicenter, Randomized, Phase III Study of S-1 and Cisplatin Compared with 5-FU and Cisplatin in patient with metastatic Diffuse Gastric Cancer Previously Untreated with Chemotherapy

An Open-Label, Multicenter, Randomized Phase 2 Study Evaluating the Safety and Efficacy of Ramucirumab (IMC 1121B) Drug Product or IMC 18F1 in Combination With Capecitabine or Capecitabine Monotherapy, in Unresectable, Locally Advanced or Metastatic Breast Cancer Patients Previously Treated With Anthracycline and Taxane Therapy

An Open-Label, Randomized, Phase 2 Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Patients with Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma

An Open-Label, Single-Arm Multicenter Phase 2 Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy

An open label two-stage study of orally administered BKM120 in patients with metastatic non-small cell lung cancer with activated PI3K pathway

An open label, randomized, multicenter phase 2 trial of dasatinib vs dasatinib plus smoothened antagonist (BMS 833923) in the treatment of subjects with newly diagnosed Chronic Phase Philadelphia Chromosome Positive CML

An open-label, multicenter, multinational study of Lacosamide as first add-on antiepileptic drug (AED) treatment in subjects with partial-onset seizures Protocol SP954

An open-label, randomized, multi-center, Phase III study to compare the safety and efficacy of TKI258 versus sorafenib in patients with metastatic renal cell carcinoma after failure of anti-angiogenic and mTOR therapies

C-09-035 - Clinical Investigation of AcrySof® IQ ReSTOR® Multifocal Toric IOL Model SND1T2

CALGB 30610/RTOG 0538: Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide

Dose Escalating Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) for Patients with Hepatic Metastases

E3F05 Phase III Study of Radiation Therapy with or without Temozolomide for Symptomatic or Progressive Low-Grade Gliomas

E6508: A Phase II Study of L-BLP25 and Bevacizumab in Unresectable Stage IIIA and IIIB Non-Squamous Non-Small Cell Lung Cancer after Definitive Chemoradiation

E7208: A Randomized Phase II Study of Irinotecan and Cetuximab With or Without the Anti-Angiogenic Antibody, Ramucirumab (IMC-1121B), in Advanced, K-ras Wild-Type Colorectal Cancer Following Progression on Bevacizumab-Containing Chemotherapy

EVALUATION OF LOW EMISSION NEOSYNC EEG SYNCHRONIZED TMS TECHNOLOGY FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER: A MULTICENTER RANDOMIZED, DOUBLE-BLIND, SHAM-CONTROLLED, TRIAL

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory partial Seizures in a Double-Blind, Randomised, Placebo-Controlled, Parallel-Group, Multicentre Clinical Trial

Evaluation of Systemic Hypothermia Initiated After 6 Hours of Age in Infants > or equal to 36 Weeks Gestation with Hypoxic-Ischemic Encephalopathy: A Bayesian Evaluation (Late Hypothermia Study for HIE)

Functional Ambulation: Standard Treatment vs. Electrical Stimulation Therapy (FASTEST) Trial in Chronic Post-Stroke Subjects with Foot Drop

GOG 0254: A Phase II Evaluation of SU11248 (Sunitinib Malate) (IND# 74019, NSC# 736511) in the Treatment of Persistent or Recurrent Clear Cell Ovarian Carcinoma

GOG 0724: Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or without Adjuvant Chemotherapy in High-Risk Patients with Early-stage Cervical Carcinoma Following Radical Hysterectomy

GOG 212: A Randomized Phase III Trial of maintenance chemotherapy comparing 12, monthly cycles of single agent Paclitaxel or Xyotax (CT-2103) (IND# 70177), versus no treatment until documented relapse in women with advanced Ovarian or primary Peritonel cancer who achieve a complete clinical response to primary Platinum/Taxane Chemotherapy

GOG 238: A Randomized Trial of Pelvic Irradiation with or without Concurrent Weekly Cisplatin in Patients with Pelvic-only Recurrence of Carcinoma of the Uterine Corpus

GOG 240: A Randomized Phase III Trial of Cisplatin Plus Paclitaxel With and Without NCI-Supplied Bevacizumab (NSC #704865, IND #113912) Versus the Non-Platinum Doublet, Topotecan Plus Paclitaxel, With and Without NCI-Supplied Bevacizumab, In Stage IVB, Recurrent or Persistent Carcinoma of the Cervix

GOG 249: A Phase III Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin in Patients with High-Risk, Early Stage Endometrial Cancer

GOG 250: A Randomized Phase III evaluation of Docetaxel (NSC #628503) and Gemcitabine (NSC #613327) Plus G-CSF With Bevacizumab (NSC #704865, IND #113912) Versus Docetaxel (NSC #628503) and Gemcitabine (NSC #613327) Plus G-CSF With Placebo in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus

GOG 258: A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel for Optimally Debulked, Advanced Endometrial Carcinoma

GOG 261: A Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Ifosfamide Plus Paclitaxel in Chemotherapy-Naïve Patients with Newly Diagnosed Stage I-IV, Persistent or Recurrent Carcinosarcoma (Mixed Mesodermal Tumors) of the Uterus

GOG 262/ACRIN 6695: A Randomized Phase III Trial of Every-3-Weeks Paclitaxel Versus Dose Dense Weekly Paclitaxel in Combination with Carboplatin with or without Concurrent and Consolidation Bevacizumab (NSC 704865, IND #7921, 113912) in the Treatment of Primary Stage II, III or IV Epithelial Ovarian, Peritoneal or Fallopian Tube Cancer

GOG 264: A Randomized Phase II Trial of Paclitaxel and Carboplatin vs. Bleomycin, Etoposide, and Cisplatin for Newly Diagnosed Advanced Stage and Recurrent Chemonaive Sex Cord-Stromal Tumors of the Ovary

GOG 9918: A Phase I Trial of Tailored Radiation Therapy With Concomitant Cetuximab (C225, NSC #714692) and Cisplatin (NSC #119875) in the Treatment of Patients with Cervical Cancer

GOG-0127W: A Phase II Evaluation of ABT-888 (IND#77840, NSC #737664), Topotecan (NSC #609699) and Filgrastim or Pegfilgrastim in the Treatment of Persistent or Recurrent Squamous or Non-Squamos Cell Carcinoma of the Cervix

GOG-0186J: A Randomized Phase IIB Evaluation of Weekly Paclitaxel (NSC #673089) Plus Pazopanib (NSC #737754) vs. Weekly Paclitaxel Plus Placebo in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma

I-SPY 2 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2)

Identification and Treatment of Clinically Silent Catheter-related Deep Vein Thrombosis in Children with Cancer

Interstitial Radioactive Iodine Implants for the Treatment of Pan-invasive Pituitary Macroadenomas

NGR015: Randomized double-blind phase III study of NGR-hTNF plus best investigator's choice (BIC) versus placebo plus BIC in previously treated patients with advanced malignant pleural mesothelioma (MPM)

Neoadjuvant Everolimus (RAD001) For Advanced RCC before Cytoreductive Nephrectomy, With Correlative Tumor Studies

Novel Treatment of Emotional Dysfunction in PTSD

PPHM 1002: A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients with Previously Untreated Stage IV Pancreatic Cancer

Phase 3, Randomized, Open-Label Study of the Efficacy and Safety of Crizotinib Versus Pemetrexed/Cisplatin or Pemetrexed/Carboplatin in Previously Untreated Patients with Non-Squamous Carcinoma of the Lung Harboring a Translocation or Inversion Event Involving the Anaplastic Lymphoma Kinsase (ALK) Gene Locus

Phase I Study of Accelerated Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients with Stage II-IV Non-Small Cell Lung Cancer and Poor Performance Status

Phase I Study of An Autologous Idiotype Vaccine Manufactured by magnICON® Technology for the Treatment of Patients with Follicular Lymphoma in First Relapse/Progression

Phase I/II Study of PX-866 and Docetaxel in Patient with Solid Tumors

Phase I/II Trial of Fenretinide/LXS oral powder (NSC 374551) plus Ketoconazole in Recurrent Ovarian Cancer and Primary Peritoneal Carcinoma

Phase II Study of Preoperative Radiation with Concurrent Capecitabine, Oxaliplatin and Bevacizumab Followed by Surgery and Postoperative 5-FU, Leucovorin, Oxaliplatin (FOLFOX) and Bevacizumab in Patients with Locally Advanced Rectal Cancer

Phase II Trial of Hippocampal-Avoiding Whole Brain Irradiation with Simultaneous Integrated Boost for Treatment of Brain Metastases

Protocol N01358 A Randomized, Double-Blind, Placebo Controlled, Multicenter, Parallel Group Study To Evaluate The Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 80 Years Old) with Partial Onset Seizures.

Protocol N01379: An Open-Label, Multicenter, Follow-up Study to Evaluate the Long-Term Safety and Efficacy of Brivaracetam Used as Adjunctive Treatment in Subjects Aged 16 Years or Older with Epilepsy.

Protocol P261-401: A Randomized, Double Blind, Placebo Controlled Study of the Safety and Efficacy of Intranasal Midazolam in the Outpatient Treatment of Subjects with Seizure Clusters

REd CEll Storage Duration Study (RECESS)

RTOG 0813: Seamless Phase I/II Study of Stereotactic Lung Radiotherapy (SBRT) for Early Stage, Centrally Located Non-Small Cell Lung Cancer (NSCLC) in Medically Inoperable Patients

RTOG 0837: Randomized, Phase Il, Double-Blind, Placebo-Controlled Trial Of Conventional Chemoradiation And Adjuvant Temozolomide Plus Cediranib Versus Conventional Chemoradiation And Adjuvant Temozolomide Plus Placebo In Patients With Newly Diagnosed Glioblastoma

RTOG 1005: A Phase III Trial of Accelerated Whole Breast Irradiation with Hypofractionation plus Concurrent Boost Versus Standard Whole Breast Irradiation plus Sequential Boost for Early-Stage Breast Cancer

RTOG 1008 A RANDOMIZED PHASE II STUDY OF ADJUVANT CONCURRENT RADIATION AND CHEMOTHERAPY VERSUS RADIATION ALONE IN RESECTED HIGH-RISK MALIGNANT SALIVARY GLAND TUMORS

RTOG 1010 A PHASE III TRIAL EVALUATING THE ADDITION OF TRASTUZUMAB TO TRIMODALITY TREATMENT OF HER2-OVEREXPRESSING ESOPHAGEAL ADENOCARCINOMA

RTOG 1014: A Phase II Study of Repeat Breast Preserving Surgery and 3D-Conformal Partial Breast Re-Irradiation (PBRI) For Local Recurrence of Breast Carcinoma

RTOG 1021 A Randomized Phase III Study of Sublobar Resection (+/- Brachytherapy) versus Stereotactic Body Radiation Therapy in High Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC)

RTOG 534 A Phase III Trial Of Short Term Androgen Deprivation With Pelvic Lymph Node Or Prostate Bed Only Radiotherapy (SPPORT) In Prostate Cancer Patients With A Rising PSA After Radical Prostatectomy

RTOG 631 Phase II/III study of image-guided radiosurgery/SBRT for localized spine metastasis

RTOG 815 PHASE III PROSPECTIVE RANDOMIZED TRIAL OF DOSE-ESCALATED RADIOTHERAPY WITH OR WITHOUT SHORT-TERM ANDROGEN DEPRIVATION THERAPY FOR PATIENTS WITH INTERMEDIATE-RISK PROSTATE CANCER

RTOG 920 A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer

Randomized Phase II Study of Everolimus Alone versus Everolimus plus Bevacizumab in Patients with Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors

Randomized Phase II Trial of Adjuvant Combined Epigenetic Therapy with 5-Azacitidine and Entinostat in Resected Stage I Non-Small Cell Lung Cancer Versus Standard Care

Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase 3 Study of Denosumab as Adjuvant Treatment for Women with Early-Stage Breast Cancer at High Risk of Recurrence (D-CARE)

SBRT Spine: Phase II Study of Stereotactic Body Radiation Therapy and Vertebroplasty for Localized Spinal Metastasis

The Duration of Octreotide Study. An Assessment of the Duration of Continuous Intravenous Octreotide in Patients with Portal Hypertension and Esophageal Variceal Hemorrhage

Wavelength Restricted Light Therapy for Fatigue in multiple Sclerosis: A Pilot Study

Other

A Blood Based Assay for the Diagnosis of Early Stage Lung Cancer

A Longitudinal, Case-Control Study to Collect Medical and Epidemiological Data and Blood Samples for Research Into the Causes of Multiple Sclerosis and Selected Demyelinating Diseases

A Multicenter Study of Hematopoietic Stem Cell Donor Safety and Quality of Life

A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor or Hematologic Malignancy

A Prospective Evaluation of the Accuracy of Weight Estimation Using the Broselow Tape with an Adjustment Factor for Overweight and Obese Pediatric Patients in the Emergency Department

A randomized, prospective, double blind, placebocontrolled, phase 3 study of US-ATG-F prophylaxis as a supplement to standard of care prophylaxis to prevent moderate to severe chronic GVHD in adult acute myeloid leukemia, acute lymphoid leukemia, and myelodysplastic syndrome patients after allogeneic stem cell transplantation from unrelated donors

AAML08B1, Biology Study of Transient Myeloproliferative Disorder (TMD) in Children with Down Syndrome (DS)

ACCL0431, A Randomized Phase III Study of Sodium Thiosulfate for the Prevention of Cisplatin-Induced Ototoxicity in Children

ALD518 A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy

ALTE05N1, Umbrella Long-Term Follow-up Protocol

ALTE07C1, Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children with Cancer

Acute on Chronic GI bleeding at Parkland memorial Hospital

Adjunctive Contingency Management to Promote Smoking Abstinence

An Analysis of Genomic and Molecular Profiles of Lung Cancer for the Prediction of Response to Therapy and Clinical Outcomes

An Inter-Personal Framework for Lung Cancer Decision-Making in African Americans

An Intervention Promoting HPV Vaccination in Safety-net Clinics

An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

An analysis of the association between sociodemographic factors and delays to cancer treatment

Analysis of endothelial cells in rheumatoid arthritis

Auditing Race and Ethnicity Electronic Data Sources for the Capacity to Determine Adequate Minority Enrollment in Cancer Trials at UT Simmons Cancer Center and Parkland Hospital

Aurora Kinase A as a Biomarker for the Detection of Bladder Cancer

Bang for the Buck : Assessing the impact of different features of a web-based decision aid to improve decision making for asymptomatic carotid disease

Banking of Tissue and Establishing Continuous Cell Lines and Xenografts From Neoplasia (South Plains Oncology Consortium Bank [SPOC])

Breast Screening & Patient Navigation (BSPAN2): Evaluating a De-Centralized Regional Delivery System for Rural Underserved

CancerGene Connect

Childhood Cancer Survivor Study Expansion: Long-Term Follow-up Study

Comparing Outcomes after Cystectomy based on status of molecular markers

Coping with Cancer II

Database Registry for Future Research Studies on Psychiatric Disorders Associated with Reproductive Events in Women

Descriptive Study of Children with Stroke

EMBARC-HC Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care: Healthy Control Reliability

Effects of Oral Pregabalin versus Placebo on Postoperative Pain and Morphine Consumption after Mastectomy

Evaluating Conceptual Equivalence of a HPV Vaccine and Media Exposure Survey for Spanish and English-speaking Mothers

Evaluating an Interactive Cancer Communication System (ICCS) in Lung Cancer

Evaluation of Back Pain and Coping among Survivors of Childhood Leukemia

Evaluation of Radiation-Induced Vasculopathy by Transcranial Doppler (TCD) Among Survivors of Childhood Medulloblastoma Treated with Cranial Radiation Therapy

Experience with follow up cancer care and adherence to surveillance regimens among breast and colon cancer survivors: A pilot study

Facilitating Risk-Appropriate Colorectal Cancer Testing - Testing the Cancer Risk Intake System (CRIS)

Factors associated with adolescent HPV vaccine use in UTSW and Parkland affiliated clinics

Follow-Up study of breast health outcomes and selected biomarkers in women at high risk for breast cancer: The Serial Evaluation of Ductual Epithelium (SEDE) Clinical Trial

Genetic Determinants of Keloid Formation Study

Genetic Variation in a Multi-Ethnic Population

Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of its Treatment with SorafeNib

Health Topics Survey

High Resolution Magnetic Resonance Imaging in Patients with Brain Tumors

Identification of Anxiety and Depression in Children with Cancer

Increasing colorectal cancer screening in a safety-net health system with a focus on the uninsured: benefits and costs.

Interagency Registry of Mechanically Assisted Circulatory Support

Investigating the Feasibility of Using Rapid Cine-MRI for Monitoring Moving and Deforming Tumors

Kidney Cancer New Pathway Discovery Project

Lung Cancer Mutation Consortium Protocol

Molecular Characteristics of Tumor Cells

Molecular Genetic Changes of Ovarian Cancer

Molecular Mechanisms Involved in Cancer Predisposition

National Marrow Donor Program (NMDP)- Consent for Participation and Donation of Blood Samples

Natural language processing to extract actionable findings from radiology reports

Neurophysiological Studies in Schizophrenia and Psychiatric Disorders

Occult Gastrointestinal Bleeding caused by Portal Hypertensive Gastropathy in patients with Chronic Liver Disease

Outcomes in Acute Gastrointestinal Bleeding

Parkland-UT Southwestern PROSPR Center: Colon cancer screening in a safety net: Organizational & patient factors influencing guideline-based CRC screening

Parkland-UT Southwestern PROSPR Center: Colon cancer screening in a safety net: Identifying and tracking personalized regimens for patients in clinical settings

Participation in Registry, Research Database, and Research Sample Repository for Patients Undergoing Unrelated Marrow or Stem Cell Transplants

Pathophysiology of Uric Acid Nephrolithiasis

Patient, Provider, & Institutional Effects on Latinos

Potential Role of Gastrointestinal Alkali Loss in Patients with Uric Acid Nephrolithiasis

Predicting Treatment Response Based on Hypoxia in Head and Neck Cancers using Non-Invasive Oxygen Sensitive MRI

Prospective, Longitudinal, Multinational Registry of Patients with Newly Diagnosed Peripheral T-Cell Lymphoma

Research to Evaluate an Effective Community-level Intervention for Young Black Men Who Have Sex with Men

Retrospective Chart Review of Lung Cancer Patients from 2000 to 2008

Risk Factor Analysis of Hereditary Breast and Ovarian Cancer

Sentinel Lymph Node Working Group Data Acquisition Project

Standardizing creatinine clearance estimation for the Calvert formula to improve the safety and efficacy of carboplatin

Television Tip-Over Injury Prevention Education in the Greater Dallas Community

Temporal Gene Expression Profiling in the Blood of Patients with Demyelinating Disease Treated with Steroids.

The Genetics of Fatty Liver Disease

The Impact of Computerized Physician Order Entry on Antibiotic Administration in Febrile Sickle Cell Patients in the Pediatric Emergency Department

The Management and Outcome of Gestational Trophoblastic Disease

The Management and Outcome of Invasive/In Situ Cervical Carcinoma

The Management and Outcome of Uterine Cancer

The Natural History of CMV-Related Hearing Loss and the Feasibility of CMV Screening as Adjunct to Hearing Screening in Newborns

The Utility of Atropine in Pediatric RSI - A Change in the Standard of Care

The influence of a cancer diagnosis on smoking cessation efforts and outcomes

The origins of resistance to hormonal therapy in advanced prostate cancer

Tissue Procurement and Outcome Collection for Patients with Hematologic Malignancies

Transfusional Iron Overload in Children Treated for Cancer

Translational Research Evaluating Neurocognitive Memory Processes (TREC-MP)

Use of the CA-125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women

Validation of Computerized Cognitive Assessment in Cross Cultural Populations

Validation of screening questions for low health literacy in a large population of English and Spanish-speaking adults